Cardiac biomarkers and left ventricular hypertrophy in relation to outcomes in patients with atrial fibrillation: Experiences from the RE-LY trial

Ziad Hijazi, Lars Wallentin, Jonas Oldgren et al.|IrInSubria (University of Insubria)|2019

Cited by 22